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and Sustainable Open Scientific
Data
Vera J. Lipton
This chapter summarises the findings of the study by answering the research questions posed.
The chapter consists of four parts:
1. Vision:What are the expected benefits associated with the curation and release of open scientific data?
2. Policy: What is the scope of the open data policies recently introduced by research funders and
publishers?
3. Practice: How are selected data-centric public research organisations implementing open data? What
are the legal and other challenges emerging in the process of implementation? Is open scientific data
an achievable objective?
4. A way forward: What can be done to promote open access to scientific data across different research
disciplines? Is there a need to revise the open data mandates?
Introduction
This book beganwith the call from research funders and publishers for increased
access to research data so as to facilitate its increased uptake and reuse by others. The
principal triggers for the renewed emphasis on sharing research data are the open data
policies introduced by research funders and publishers inmany jurisdictions in the
world.
In this final chapter, we take a step back to review the findings of this study to
evaluate the effect of these policies on the practice of data sharing as open data. I start
with an overview of the expected benefits of open scientific data and the assumptions
that led governments to introduce the policies. This is followed by a summary of the
scope of the mandates and then an outline of the challenges associated with the
practice of open data at CERN and in clinical trials. The final section briefly summa-
rises the staged model for open scientific data introduced in the previous chapter.
9.1 Vision: what are the expected benefits associated with the curation
and open release of scientific data?
The research data landscape has changed considerably in recent years. The open
data policies introduced by research funders and publishers since 2010 have created
1
a momentum, driving research data curation and release globally, this book finds.1
Open data is developing concurrently with the open publications sector, which has
accelerated the speed and ease of making research publications freely available in
digital formats.2 The last few years have also seen the emergence of data journals
and discipline-specific data repositories that enable researchers to deposit their
research data along with publications.3
These developments are underpinned by the strong endorsements of open data
practice by major public research funders—including the National Institutes of
Health in the United States, the European Commission,4 stringent regulatory
authorities such as the European Medicines Agency (EMA),5 and esteemed research
organisations such as CERN and NASA, among many others. These actors have
championed open scientific data and are developing major infrastructures for data
deposit and discoverability.
Implicit in these developments is the understanding of the common objectives
and benefits of open scientific data—to advance and democratise science by
increasing the uptake and reuse of scientific knowledge and data, to increase the
quality and transparency of published scientific results, to enable the verification
and reproducibility of scientific results, and to facilitate the continuing shift
towards digital modes of science production and dissemination.6 Also implicit in
these benefits is the desire to find solutions to some of the biggest challenges facing
humanity and the planet today—global warming, food security and poverty, the
insatiable demand for energy and resources, increased pollution, growing urbanisa-
tion, and the quest for increased knowledge, longevity, and an improved quality of
life that increasingly depend on the application of science and technology.7
In this world of rapid technological changes, in which scientific knowledge
increasingly means power and market advantage,8 the demand for scientific knowl-
edge and data is also increasing.9 While most research remains publicly funded,10
recent years have seen an uptake of open innovation strategies by companies—
especially those that source knowledge from external sources,11 as evidenced in
growing demand for collaborations and partnerships with universities and public
research organisations.12 Such partnerships and innovation strategies have resulted in
the increased commoditisation of science by businesses—a trend that is especially
evident in the biological and medical sciences as well as in engineering.13
In this context, scientific data in the public domain has the potential to impact
the economic context in which power and control over science are distributed in
society. Open scientific data ensures that the outcomes of public science remain
available without any restrictions and for reuse by anyone, including future gener-
ations of researchers working in the public and private sectors, and anywhere in the
1 See conclusion in Chapter 3 of this book.
2 See Chapter 3, Sections 3.2 and 3.3, and Chapter 8, Sections 8.2 and 8.3.1.
3 See Chapter 3, Section 3.2.
4 Ibid.
5 See Chapter 6, Section 6.2 and Chapter 7, Section 7.5.3.
6 See Chapter 2, Sections 2.3 and 2.4.
7 See Chapter 1, Section 1.1.1.
8 See Chapter 2, Section 2.2 and Footnote 57.
9 Ibid, Footnote 57.
10 See Chapter 2, Section 2.5, Footnote 99.
11 See Chapter 2, Section 2.5.
12 Ibid, Footnote 100.
13 See Chapter 2, Section 2.2 and Chapter 1, Section 1.1.1, Footnote 33.
2
Open Scientific Data - Why Choosing and Reusing the Right Data Matters
world. Such a practice brings about huge economic benefits for countries that invest
in the development of open data, as evidenced in the Human Genome Project and
the Global Positioning System (GPS)—two early, large-scale open data initiatives.
The Human Genome Project cost the US government US$3.8 billion to develop
and up until today has generated around US$750 billion in biotechnology industry
output in that country.14 Compare US$750 billion with just over US$1 billion
received from biotechnology licencing revenue by the top 15 universities in the
United States and just over US$400 million of commercial income received from IP
licencing by that country’s biomedical research institutes.15
The economic benefit that the United States has accrued from GPS technology
up until 2013 was estimated at about US$56 billion.16 Compare this with the less
than US$3 billion received as income from the commercialisation of research by all
universities in the United States in 2016,17 with over 85% of universities finding
themselves unable to realise enough income to cover the costs of running their
technology transfer offices.18
The economic justification of innovation is clearly on the side of open data, and
governments should not be afraid to invest in the development of open technolo-
gies. The potential benefits for local economies are enormous.
9.2 Policy: what is the scope of the open data policies recently
introduced by research funders and publishers?
Research funders and publishers have played a critical role in driving open scien-
tific data. Beyond federal governments, private not-for-profit research funders such as
the Bill and Melinda Gates Foundation andWellcome Trust have adopted open data
policies. These policies have changed the game and have, within a span of around
5 years, led researchers and their organisations to curate, document, and share their
data.19Most funders have some form of policy regarding research data management
(RDM)—ranging from requiring data management plans at the proposal stage
through to expectations about depositing and sharing data. In response to these poli-
cies, research organisations have developed or strengthened internal RDM functions.
These policy adjustments vest the responsibility for data curation and release in
researchers. The policies vary in their scope and in the specific requirements for
sharing research data. Some policies ‘recommend’ or ‘strongly encourage’ data
sharing, while others ‘require’ it. Several policies explicitly ‘mandate’ data sharing
for research that receives grant money and stipulate requirements on when, how,
and what data should be deposited and where.20 The Public Library of Science
mandates data availability as a condition of publication. Other journals, such as
Nature and Science, expect researchers who publish within their pages to provide
data ‘on request’, without requiring the deposit of data on the date of publication.
The first evaluations of these policies have found a strong correlation exists
between the existence of data policies and data deposit practice.21 Another
14 Chapter 2, Section 2.5, under Human Genome Project.
15 See Chapter 2, Section 2.5, Footnote 124.
16 Ibid, under Global Positioning System.
17 See Chapter 2, Section 2.5, Footnote 124.
18 Ibid.
19 See Chapter 3, Conclusion, and Sections 3.2 and 3.3.
20 See Chapter 3, Section 3.4.
21 See Chapter 6, Section 6.1, Footnote 15.
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important finding is that more prescriptive policies—those with a mandate for data
deposit along with a statement on data sharing included in the manuscript, have
achieved the greatest deposit rates.22
However, a major theme that has emerged in this book is that the meaning of
‘research data’ varies across scientific disciplines, across various levels of data
processing, and can originate from many different sources.23 In addition, research
practices vary widely across scientific disciplines and so does the collection and
preparation of open access data.
The inability to clearly acknowledge and articulate the heterogenous nature of
research data is amajor shortcoming of the open datamandates; this book has argued.24
In particular, the opening up of research data requires adopting an openmindset and the
acknowledgement that ‘one size does not fit all’; amindset that finds RDM is an ongoing
process that is as important a driver of improved science as is the resulting open data.
Another key finding is that the quality of open data is farmore important than quantity.
More open scientific data, by itself, does not necessarily lead tomore open science,more
easily reproducible science, or improved and data-driven science.
This study cautions against any standardised approach to defining ‘data’. While
such approaches have generally proved useful when developing open access to
publications, such approaches are neither suitable nor appropriate for open scien-
tific data, this book argues.25 If open scientific data is to be sustainable, then
cultural, research practice, and organisational issues must first be addressed.
Yet librarians and research funders, who play pivotal roles in facilitating open
access to scientific publications, tend to apply the same ‘standardised’ principles
and approaches to research data. In particular, many librarians are calling for the
standardisation of research data formats and metadata descriptors for inclusion in
the policies of research funders and publishers.26 This creates confusion and chal-
lenges for researchers, who are required to comply with the mandates introduced
by research funders but are unable to do so because the complexity and heteroge-
nous nature of open data simply makes it impossible for them to apply the same set
of rules to every research project and dataset.
Common language and search structures can indeed facilitate discoverability of
data. However, every dataset is unique, requiring different languages to describe
the data and provide all supporting documentation, software, algorithms, and
metadata so as to facilitate the reuse of the data. In this sense, research data is more
analogous to archival materials rather than to open publications.
The experience from CERN is that only researchers can develop the necessary
data descriptors and that these descriptors need to be rigorously tested and embed-
ded in research practice before any common language and data structures can be
contemplated.27 In other words, attempts at research data standardisation need to
be driven bottom-up, by researchers. External approaches that would impose com-
mon descriptors on research data would be unhelpful unless the descriptors are
already firmly established in research practice. Given the recent and novel nature of
open scientific data, such pilots are only just now starting to emerge. The notion of
research data and its structuring and sharing require more refinement.
22 Ibid, Footnote 17.
23 See Chapter 4, Sections 4.1 and 4.2.
24 See Chapter 4, Conclusion.
25 See Chapter 8, Sections 8.1 and 8.2
26 See Chapter 3, Section 3.4.
27 See Chapter 5, Sections 5.3 and especially 5.3.4.
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In the meantime, open data as a default practice seems appropriate for data
underpinning scientific publications—to facilitate the validation of results. Yet
‘open by default’ is not, at this stage, feasible for data produced in clinical trials and
data collected in particle physics experiments, even though well-documented and
well-curated digital data, including raw data and metadata, is generally available.
Most of the data can only be shared with expert collaborators. Carefully selected
subsets of the data are, however, increasingly becoming available as open data for
educational purposes. Open data is also paving the way for making scientific exper-
iments more accessible to wider audiences.
9.3 Practice
9.3.1 How are selected data-centric public research organisations implementing
open data? Is open scientific data an achievable objective?
In assessing early experiences with open scientific data at CERN and with clini-
cal trial data, this book finds that curating scientific data for public release is far
more complex and costly than governments and research funders had envisaged.
The major complication is that implementing open scientific data requires
appropriate RDM. Public research organisations in general, and universities in
particular, have very limited experience in this area.28 Furthermore, the key stake-
holders in the process have different, often conflicting, interests, and concerns
about research data.
For researchers, the need to ensure the ethics and validity of secondary data
analyses and the recognition of their efforts vested in data curation are the most
prominent concerns. From the perspective of research sponsors and publishers,
safeguarding their economic interests through intellectual property and confidenti-
ality remain important considerations that directly challenge the practice of open
scientific data.
Understanding the requirements for responsible data sharing and ensuring
compliance with these requirements pose fresh challenges to research organisations.
Maintaining the privacy of subjects involved in data collection, particularly in
clinical trials, is an additional concern for medical research institutes. Furthermore,
digital curation of research data is labour and resource-intensive and requires sub-
stantial investments in data infrastructures and new business models. In this con-
text, many research organisations point out that open scientific data should not be
an unfunded mandate. This is particularly the concern among researchers collecting
clinical trial data, who fear that the funding needed for data curation will diminish
the resources available to conduct new trials.29
The lessons learnt with implementing open data at CERN can prove helpful to
other research organisations active in different areas of science. One particular area
of emerging best practice is that the implementation of open data within organisa-
tions needs to be embraced and discussed by all—researchers, management and
librarians. At CERN, such discussions were initiated through the development of
internal open data preservation and sharing policies within the four main research
teams. The vigorous debate that occurred at many different levels during the pro-
cess transformed the whole organisation, including its conduct of data-driven
research.30 The resulting open data policies have created a shared understanding of
28 See Chapter 5, Section 5.1.
29 See Chapter 6, Section 6.2.4, Footnotes 72 and 73.
30 See Chapter 5, Sections 5.3, and Conclusion.
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the processes leading to data reusability and established the potential for data
sharing with external users.31
One particular finding at CERN was that the value of open scientific data lies
primarily in its quality, determined by two factors—robust data management prac-
tices within organisations and the potential in open data for future use and reuse.32
From this came the development of the Open Data portal at CERN.
Despite these learnings and insights, CERN has not yet made available as open
data all the data it produces. It has divided prospective users into four groups—
ranging from a base level, offering direct access by anyone to the data underlying
publications, through to the restricted access to the entire raw dataset only available
to selected expert collaborators. This user hierarchy is necessary because CERN
does not, at this time, have the data-processing capacity to accommodate universal
and unrestricted access and also because some of the data requires knowledge of
particle physics to understand and reuse it.33
In medicine, the sharing of clinical trial and genomic data has been an
established practice for several years. It has gained new momentum with the release
of open data mandates by research funders, by publishers, and especially by the
EMA. New requirements for data sharing have also lead to greater transparency and
increased data sharing in industry. Open sharing of data submitted to regulatory
authorities has been tested by courts, which have upheld, in all cases, the open
approach championed by the EMA.34
The key consideration in sharing patient-level data as open data is the protection
of privacy and confidentiality. Research organisations have dealt with these con-
cerns for many years and have in place well-tested procedures for research ethics
along with data sharing protocols.35 These are supported by the rigorous training of
researchers, including the certification of researchers who collect and work with
data involving human subjects.
However, recent unauthorised data sharing and privacy breaches by several
large companies have brought renewed attention from policymakers to ensuring
data privacy and confidentiality. As the result of the widespread publicity for
privacy breaches at companies such as Facebook and Yahoo, policymakers are
seeking to interfere with established decentralised research practice and to institute
centrally controlled mechanisms to manage the privacy and confidentiality of data,
with the vetting of prospective users.36 In particular, this is the policy approach
adopted by governments in the United Kingdom, New Zealand and, very recently,
in Australia. There is a proposal to apply this approach to research data and, on first
sight, it appears that it would apply to all research data.37
Such centralised approaches are unlikely to yield the desired economic and social
benefits that open data presents. If there is one lesson learnt from the remarkable
growth of the biomedical industry in Europe and the United States, it is that
decentralised and open research can accelerate the pace of discovery and innova-
tion, fuel economic growth and strengthen global competitiveness. This potential
can only be realised if research data is available broadly and is reused by others.
31 Ibid.
32 See Chapter 5, Conclusion.
33 See Chapter 5, Section 5.2.2.
34 See Chapter 7, Section 7.5.3.
35 See Chapter 6, Sections 6.2.1 and 6.2.2, and Chapter 7, Section 7.5.
36 See Chapter 7, Section 7.5.4.
37 Ibid.
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Another important issue that has emerged in the implementation of open data,
both at CERN and in clinical trials, is the necessity to define the levels of processing
and other parameters that can make data reusable by others. Best practice in both
fields confirms that research data, software and metadata—the three components of
research data generally specified in the policies of research funders and publishers
—are not sufficient to enable independent data reuse.38
Also required is a detailed description of the assumptions made by the original
data collectors during the different stages of their research and data analysis, along
with the statistical methods used to clean, process, aggregate and analyse the data.
Such steps are rarely recorded as part of research practice and more study is needed
to determine the scope and level of documentation required to achieve data reus-
ability across different scientific disciplines and projects.
With this in mind, it is important for research funders across the different
scientific disciplines to ascertain the levels at which scientific data is generally
collected and processed across each scientific discipline. Funders should then set the
boundaries for the levels at which the data holds the highest potential for reuse by
others, whether as researchers (expert users) or as other interested users.
In addition, there is the need for reconsideration of the calls by research funders
and policymakers for research reproducibility. This study finds that sharing of
research data as open data does not necessarily or easily lead to research reproduc-
ibility. Low-level data (raw data) are generally required for this purpose and such
data may not be readily available for sharing as open data or they can be costly to
curate. Even where low-level data and all supporting analyses, algorithms and
software are meticulously documented and are made available, experts in the same
field of science may not achieve duplicate results by reusing the same data and
applying the same techniques.39
Moreover, reproducibility studies can be costly, as evidenced in clinical trials
and experienced first-hand by biomedical companies trying to replicate the research
of competitors.40 Therefore, reproducibility should only be the desired and stated
objective in carefully selected research areas or research projects—such as those
designed by drug regulators or those commissioned by courts to verify ambiguous
claims made by pharmaceutical companies in their marketing applications for the
approval of new products. Reproducibility should not be held as the ‘golden stan-
dard’ for science,41 and it should not be one of the key objectives for open scientific
data that research funders advocate.
9.3.2 What are the legal and other challenges emerging in the process of
implementation?
Depositing research data in the public domain has highlighted the need to
determine the legal owner of the dataset.42 Uncertainties around the application of
copyright to the various forms of data, and around data ownership in the research
sector and in academia, have been identified as the root causes of subsequent
problems affecting data licencing and the lack of clarity around conditions
governing data reuse.43
38 See Chapter 8, Section 8.3.6.
39 See Chapter 6, Section 6.4.3.
40 Ibid.
41 Ibid.
42 See Chapter 7, Section 7.2 and Conclusion and Chapter 8, Section 8.3.8.
43 Ibid.
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A further concern is the duty of fidelity that researchers have to their employers,
which may prevent them from disclosing information acquired in the course of
their employment.44 The duty of confidentiality may also arise in collaborations
with private sector sponsors. This book recommends more analysis of the relation-
ship between the ownership of research data, in its different forms, and the inter-
play of that with possible copyright protection and confidentiality issues.45
Reuse of open data can give rise to legal problems, especially in the context of text
and data mining, which is necessary to extract value and insight from datasets.46
Since data mining typically requires the making of a (temporary) copy of the dataset,
it is likely that the act of copying would amount to copyright infringement.
In this matter, compared with their counterparts in the United States, Europe
and in other parts of the world, Australian research organisations seem disadvan-
taged. Such an inhibition for text and data mining also makes Australia a less
attractive destination for data-driven businesses. This study proposes introducing a
text and data mining exemption into the Australian Copyright Act 1968 [496].47
9.3.3 Is open scientific data an achievable objective?
Taken together, the lessons learnt from the implementation of open scientific
data—along with the financial and research benefits accrued from open data to this
point, the potential future benefits and the increased need in the digital era for
researchers to gain faster access to research data to conduct research—lead to the
conclusion in this book that open scientific data is indeed an achievable objective
and should become a priority for all research organisations.
However, curating all publicly funded research data as open data is not possible
with current technology, nor it is currently achievable at recoverable cost. There
remain necessary choices about what data to select for curation and release as open
data.
The staged model proposed in this book offers some suggestions on how choices
can be made so as to balance the individual responsibilities of researchers for
curating research data with the collective benefits likely to accrue to other
researchers and to society through reuse of the data.
9.4 A way forward: what can be done to promote open access to
scientific data across different research disciplines? Is there a need
to revise the open data mandates?
This book found that the open data mandates as they stand today do not
acknowledge the diversity of research data as it occurs across different research
disciplines and at different stages of processing and control. No uniform answers
exist for the question of what defines data, and therefore, it is also difficult to
determine what data is worth preserving into the future.
The staged model proposed in the preceding chapter encourages research orga-
nisations to define the content of the data they hold as well as to define the stages of
its processing. This model, along with eight recommendations, presents a roadmap
towards more achievable and sustainable open scientific data.
44 See Chapter 7, Section 7.5 and Chapter 8, Section 8.3.8.
45 Ibid.
46 See Chapter 7, Section 7.4 and Chapter 8, Section 8.3.9.
47 Ibid.
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The proposed model includes four levels of data processing and release. It calls
for default and immediate open access to data that underpins results published in
scientific publications (Level 1 data). The staged model recognises the value open
that data can deliver if it is used for educational and outreach purposes, as demon-
strated with Level 2 data at CERN. The proposed model also recognises that not all
research data can be of interest to the general public and that there are certain risks
associated with sharing some types of data. Therefore, the model proposes that
Levels 3 and 4 data may not be shared immediately after the publication of research
results and that such data should be restricted for reuse by expert users with
relevant competence.48
The factors that drive the independent reuse of open data are not known at this
stage and will emerge over time as open data collections increase and gain in value.
For now, open data practice may not be easy to implement, yet the individual and
organisational lessons learnt are significant discoveries on the transformational
journey to digital science.
As technologies evolve and as our ability to work with open data increases, the
value of open data will increase also. Those governments, researchers, and organi-
sations that learn to share their research data, and that learn to harness the value of
data released by others, will become the visionaries to lead us into a data-enriched
future.
“We must believe that we are gifted for something, and that this thing, at whatever
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